NasdaqCM - Delayed Quote USD

Basel Medical Group Ltd (BMGL)

3.9300

+0.0100

+(0.26%)

At close: June 6 at 4:00:01 PM EDT

3.9600

+0.03

+(0.76%)

After hours: June 6 at 7:59:25 PM EDT

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Mr. Keng Leong Fung	Executive Chairman of the Board	--	--	--
Dr. Yen Feng Chhoa M.D.	Group Chief Health Officer & Interim CEO	--	--	1988
Ms. Jianing Lu	Group CFO & Director	--	--	1990
Mr. Wee Keong Teo	Group Chief Partnership Officer	--	--	1974

6 Napier Road

Unit No. 02-10/11 Gleneagles Medical Centre

Singapore, 258499

Singapore

65 6291 9188 https://baselmedical.com

Sector:: Healthcare
Industry:
Full Time Employees:: 32

Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as other complex neurosurgical procedures. Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions, as well as physiotherapy services. The company was incorporated in 2023 and is headquartered in Singapore.

Basel Medical Group Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events Information Not Available

June 3, 2025 at 12:00 AM UTC